These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15846221)

  • 1. RU486 inhibits expression of lysophosphatidic acid induced glycodelin.
    Ramachandran S; Song MQ; Lowe E; Dominguez CE; Parthasarathy S; Murphy AA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1285-93; discussion 1293-4. PubMed ID: 15846221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid induces glycodelin gene expression in cancer cells.
    Ramachandran S; Ramaswamy S; Cho Ch; Parthasarathy S
    Cancer Lett; 2002 Mar; 177(2):197-202. PubMed ID: 11825667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
    Yin P; Roqueiro D; Huang L; Owen JK; Xie A; Navarro A; Monsivais D; Coon JS; Kim JJ; Dai Y; Bulun SE
    PLoS One; 2012; 7(1):e29021. PubMed ID: 22272226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.
    Luo X; Yin P; Reierstad S; Ishikawa H; Lin Z; Pavone ME; Zhao H; Marsh EE; Bulun SE
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4533-9. PubMed ID: 19808856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promegestone (R5020) and mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells.
    Taylor RN; Savouret JF; Vaisse C; Vigne JL; Ryan I; Hornung D; Seppälä M; Milgrom E
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4006-12. PubMed ID: 9814484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAT1 regulates growth of uterine leiomyoma smooth muscle cells.
    Xia Luo ; Coon JS; Su E; Pearson EK; Ping Yin ; Ishikawa H; Bulun SE
    Reprod Sci; 2010 Sep; 17(9):791-7. PubMed ID: 20601542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells.
    Koistinen H; Seppälä M; Nagy B; Tapper J; Knuutila S; Koistinen R
    Am J Obstet Gynecol; 2005 Dec; 193(6):1955-60. PubMed ID: 16325596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glycodelin levels in gynecological malignancies.
    Horowitz IR; Cho C; Song M; Flowers LC; Santanam N; Parthasarathy S; Ramachandran S
    Int J Gynecol Cancer; 2001; 11(3):173-9. PubMed ID: 11437921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
    Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
    Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells.
    Chen W; Yoshida S; Ohara N; Matsuo H; Morizane M; Maruo T
    J Clin Endocrinol Metab; 2005 Feb; 90(2):884-92. PubMed ID: 15536154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.
    Patel A; Malik M; Britten J; Cox J; Catherino WH
    Fertil Steril; 2016 Apr; 105(4):1102-10. PubMed ID: 26776909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
    Senturk LM; Sozen I; Gutierrez L; Arici A
    Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycodelin gene expression in human peripheral white blood cells.
    Lang EE; Venkatraman G
    Ir J Med Sci; 2007; 176(2):101-4. PubMed ID: 17570010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidants and antioxidants affect the expression of glycodelin.
    Ramachandran S; Rong R; Parthasarathy S
    Free Radic Biol Med; 2003 Apr; 34(7):818-23. PubMed ID: 12654469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells.
    Xu Q; Takekida S; Ohara N; Chen W; Sitruk-Ware R; Johansson ED; Maruo T
    J Clin Endocrinol Metab; 2005 Feb; 90(2):953-61. PubMed ID: 15572421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
    Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
    Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
    Chegini N; Tang XM; Ma C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycodelin levels in uterine flushings and in plasma of patients with leiomyomas and polyps: implications for implantation.
    Richlin SS; Ramachandran S; Shanti A; Murphy AA; Parthasarathy S
    Hum Reprod; 2002 Oct; 17(10):2742-7. PubMed ID: 12351556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
    Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
    Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.